Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression-Reference-Cited by-同舟云学术

Glucagon-Like Peptide-1 Receptor Agonist Inhibits Asymmetric Dimethylarginine Generation in the Kidney of Streptozotocin-Induced Diabetic Rats by Blocking Advanced Glycation End Product–Induced Protein Arginine Methyltranferase-1 Expression

Published:2013-01 Issue:1 Volume:182 Page:132-141
ISSN:0002-9440
Container-title:The American Journal of Pathology
language:en
Short-container-title:The American Journal of Pathology

Author:

Ojima Ayako,Ishibashi Yuji,Matsui Takanori,Maeda Sayaka,Nishino Yuri,Takeuchi Masayoshi,Fukami Kei,Yamagishi Sho-ichi

Funder

Ministry of Education, Culture, Sports, Science and Technology

Publisher

Elsevier BV

Subject

Pathology and Forensic Medicine

Reference49 articles.

1. Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptors;Vlassara;Diabetes Suppl,1996

2. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications;Brownlee;N Engl J Med,1998

3. Novel inhibitors of glycation and AGE formation;Rahbar;Cell Biochem Biophys,2007

4. Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice;Yamamoto;J Clin Invest,2001

5. RAGE drives the development of glomerulosclerosis and implicates podocyte activation in the pathogenesis of diabetic nephropathy;Wendt;Am J Pathol,2003

Cited by 135 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Biomarkers of Arginine Methylation in Diabetic Nephropathy: Novel Insights from Bioinformatics Analysis;Diabetes, Metabolic Syndrome and Obesity;2024-09

2. Exendin-4, a glucagon-like peptide-1 receptor agonist, alleviates muscular dysfunction and wasting in a streptozotocin-induced diabetic mouse model compared to metformin;Tissue and Cell;2024-08

3. Emerging therapeutic landscape: Incretin agonists in chronic kidney disease management;Life Sciences;2024-08

4. Role of protein arginine methyltransferase 1 in obesity‐related metabolic disorders: Research progress and implications;Diabetes, Obesity and Metabolism;2024-05-15

5. A network pharmacology, molecular docking and in vitro investigation of Picrorhiza kurroa extract for the treatment of diabetic nephropathy;Journal of Biomolecular Structure and Dynamics;2024-02-14